KRAS and non-small cell lung carcinoma: Instead of acute cell death, inhibition of KRAS-MAPK signaling in NSCLC, PDAC and melanoma models sequesters a subgroup of tumor cells in a plastic, quiescent, and CSC-like state that enables some of them to gain adaptive changes and become resistance 158, 159, 162, 197.